Tower Research Capital (TRC)’s AN2 Therapeutics ANTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.63K | Buy |
5,313
+3,231
| +155% | +$3.43K | ﹤0.01% | 4166 |
|
|
2025
Q1 | $2.83K | Buy |
2,082
+619
| +42% | +$842 | ﹤0.01% | 4499 |
|
|
2024
Q4 | $2.02K | Sell |
1,463
-2,793
| -66% | -$3.85K | ﹤0.01% | 4924 |
|
|
2024
Q3 | $4.55K | Sell |
4,256
-1,150
| -21% | -$1.23K | ﹤0.01% | 4503 |
|
|
2024
Q2 | $11.6K | Buy |
5,406
+4,293
| +386% | +$9.23K | ﹤0.01% | 4071 |
|
|
2024
Q1 | $3.62K | Buy |
1,113
+1,050
| +1,667% | +$3.41K | ﹤0.01% | 4827 |
|
|
2023
Q4 | $1.29K | Sell |
63
-2,982
| -98% | -$61.1K | ﹤0.01% | 5404 |
|
|
2023
Q3 | $49K | Buy |
+3,045
| New | +$49K | ﹤0.01% | 2565 |
|
|
2023
Q2 | – | Sell |
-2,797
| Closed | -$28K | – | 5998 |
|
|
2023
Q1 | $28K | Buy |
2,797
+1,941
| +227% | +$19.4K | ﹤0.01% | 3056 |
|
|
2022
Q4 | $8K | Sell |
856
-423
| -33% | -$3.95K | ﹤0.01% | 4361 |
|
|
2022
Q3 | $22K | Sell |
1,279
-3,083
| -71% | -$53K | ﹤0.01% | 3849 |
|
|
2022
Q2 | $34K | Buy |
4,362
+3,709
| +568% | +$28.9K | ﹤0.01% | 3237 |
|
|
2022
Q1 | $10K | Buy |
+653
| New | +$10K | ﹤0.01% | 4273 |
|